Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  Pacific Biosciences of California    P09

PACIFIC BIOSCIENCES OF CALIFORNIA (P09)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Deutsche Boerse Ag
04/19/2018 04/20/2018 04/23/2018 04/24/2018 04/25/2018 Date
2.03(c) 2.06(c) 2.03(c) 2.04(c) 2.01 Last
0 0 0 0 0 Volume
-2.40% +1.48% -1.46% +0.49% -1.47% Change
More quotes
Financials (USD)
Sales 2018 112 M
EBIT 2018 -77,7 M
Net income 2018 -80,4 M
Finance 2018 14,0 M
Yield 2018 -
Sales 2019 144 M
EBIT 2019 -63,2 M
Net income 2019 -65,9 M
Finance 2019 78,0 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 2,89x
EV / Sales2019 1,80x
Capitalization 338 M
More Financials
Company
Pacific Biosciences of California, Inc. engages in the research, development, and manufacture of sequencing systems for genetic analysis.It operates through the following geographical segments: North America, Europe, and Asia Pacific (including the Middle East).The company was founded by Stephen... 
More about the company
Surperformance© ratings of Pacific Biosciences of Cal
Trading Rating : Investor Rating :
More Ratings
Latest news on PACIFIC BIOSCIENCES OF CAL
04/21Pacific Biosciences of California, Inc. First Quarter 2018 Financial Results ..
GL
04/14PACIFIC BIOSCIENCES OF CALIFORNIA : Gains as HudsonAlpha Picks Sequel System
AQ
04/12PACIFIC BIOSCIENCES OF CALIFORNIA : HudsonAlpha Using PacBio Sequencing for Chil..
AQ
04/11HudsonAlpha Using PacBio Sequencing for Childhood Developmental Disabilities ..
GL
03/28PACIFIC BIOSCIENCES OF CALIFORNIA : Announces Ten-Unit Sequel System Order for A..
AQ
03/27Pacific Biosciences Announces Ten-Unit Sequel System Order for Annoroad
GL
03/23PACIFIC BIOSCIENCES OF CALIFORNIA : Prevails in Patent Eligibility Ruling Agains..
AQ
03/22Pacific Biosciences Prevails in Patent Eligibility Ruling Against Oxford Nano..
GL
03/22PACIFIC BIOSCIENCES OF CALIFORNIA : Patent Issued for Arrays of Integrated Analy..
AQ
03/15Study Demonstrates Potential for SMRT Sequencing to Improve the Safety of Gen..
GL
More news
Sector news : Advanced Medical Equipment & Technology - NEC
12:45pTHERMO FISHER SCIENTIFIC : 1Q Profit Increases; Lifts Guidance
DJ
04/23EUROPE MARKETS : European Stocks Hit 10-week High As Rising Bond Yields Lift Fin..
DJ
04/23Siemens CEO says rail business performed well in Q2
RE
04/23ROYAL PHILIPS : Trade war worries Philips as it banks on China growth
RE
04/23ROYAL PHILIPS : Correction to Philips 1Q Earnings Story
DJ
More sector news : Advanced Medical Equipment & Technology - NEC
Chart PACIFIC BIOSCIENCES OF CAL
Duration : Period :
Pacific Biosciences of Cal Technical Analysis Chart | P09 | US69404D1081 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 4,90 $
Spread / Average Target 92%
EPS Revisions
Managers
NameTitle
Michael W. Hunkapiller Executive Chairman, President & CEO
Susan K. Barnes CFO, Principal Accounting Officer & Senior VP
Stephen W. Turner Chief Technology Officer
Jonas Korlach Chief Scientific Officer
William W. Ericson Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PACIFIC BIOSCIENCES OF CALIFORNIA-7.94%338
THERMO FISHER SCIENTIFIC13.94%87 042
DANAHER CORPORATION7.84%70 682
INTUITIVE SURGICAL19.60%50 634
ROYAL PHILIPS10.61%39 937
BOSTON SCIENTIFIC CORPORATION16.26%39 757